The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease (Q37696521)

22 August 2017

1 reference

title

The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease (English)

1 reference

22 August 2017

0 references

1 reference

5

Frank J Gunn-Moore

1 reference

22 August 2017

Kirsty E A Muirhead

1

1 reference

22 August 2017

Eva Borger

series ordinal

2

1 reference

22 August 2017

Laura Aitken

series ordinal

3

1 reference

22 August 2017

Stuart J Conway

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

24 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

426

1 reference

22 August 2017

3

1 reference

22 August 2017

255-270

1 reference

Staging of Alzheimer-related cortical destruction

22 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Pathways by which Abeta facilitates tau pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The role of apolipoprotein E in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The role of APP processing and trafficking pathways in the formation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

21 January 2018

Amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Active and passive immunotherapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Alzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Proteolytic processing of amyloid-beta precursor protein by secretases does not require cell surface transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Profile of changes in lipid bilayer structure caused by beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intraneuronal Abeta42 accumulation in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Intramembrane proteolysis: theme and variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Structural and functional link between the mitochondrial network and the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Impaired balance of mitochondrial fission and fusion in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

JNK activation is associated with intracellular beta-amyloid accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Deposition of Alzheimer's vascular amyloid-beta is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17beta-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH2 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

What is the mitochondrial permeability transition pore?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Thioredoxins and glutaredoxins as facilitators of protein folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Thioredoxin and related molecules--from biology to health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mechanisms of action of cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Mitochondria-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20091941

21 January 2018

Identifiers

DOI

10.1042/BJ20091941

1 reference

release_gpkw4ylzxjaztf67lujjzmsdhm

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gpkw4ylzxjaztf67lujjzmsdhm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference